Ildong Pharmaceutical Co., Ltd.(KR:249420)
₩12,270.00-300.00 (-2.39%)
KR:249420
Ildong Pharmaceutical Co., Ltd. financials statements
₩12,270.00
At close:-300.00 (-2.39%)
Want to see KR:249420 full AI Analyst Report?
Ildong Pharmaceutical Co., Ltd. (249420) Income Statement
Ildong Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Ildong Pharmaceutical Co., Ltd.'s total revenue was ₩147.86B, an increase of 6.77% from the same quarter last year. In Q2, Ildong Pharmaceutical Co., Ltd.'s net income was ₩5.70B. See Ildong Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 566.93B | ₩ 614.94B | ₩ 600.76B | ₩ 637.71B | ₩ 560.13B | |
| ₩ 214.76B | ₩ 233.46B | ₩ 207.54B | ₩ 236.34B | ₩ 219.44B | |
| ₩ 197.44B | ₩ 220.34B | ₩ 260.96B | ₩ 309.68B | ₩ 273.82B | |
| Depreciation and Amortization | ₩ 22.58B | ₩ 25.94B | ₩ 28.32B | ₩ 29.54B | ₩ 29.31B |
| ₩ 39.90B | ₩ 33.59B | ₩ -51.23B | ₩ -80.49B | ₩ -101.34B | |
| ₩ 17.32B | ₩ 13.12B | ₩ -53.42B | ₩ -73.33B | ₩ -54.38B | |
| ₩ 12.25B | ₩ -23.81B | ₩ -40.86B | ₩ -46.34B | ₩ -86.83B | |
| ₩ 31.80B | ₩ -10.69B | ₩ -94.27B | ₩ -119.82B | ₩ -141.21B | |
| ₩ 27.66B | ₩ -4.58B | ₩ -78.93B | ₩ -142.17B | ₩ -99.71B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 942.08 | ₩ -163.63 | ₩ -2920.01 | ₩ -5396.73 | ₩ -4191.88 |
| Diluted EPS | ₩ 936.77 | ₩ -163.63 | ₩ -2920.01 | ₩ -5396.73 | ₩ -4191.88 |
| Weighted Average Shares Outstanding | 30.04M | 27.93M | 27.03M | 26.34M | 23.79M |
| Weighted Average Shares Outstanding (Diluted) | 30.04M | 27.93M | 27.03M | 26.34M | 23.79M |
Currency in KRW

